Proline- and Arginine-Rich Peptides as Flexible Allosteric Modulators of Human Proteasome Activity

Ma Agorzata Giziynska, Julia Witkowska, Przemysaw Karpowicz, Rafa Rostankowski, Estrella S. Chocron, Andrew M Pickering, Pawel Osmulski, Maria E Gaczynska, Elzbieta Jankowska

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Proline- and arginine-rich peptide PR11 is an allosteric inhibitor of 20S proteasome. We modified its sequence inter alia by introducing HbYX, RYX, or RHbX C-terminal extensions (Hb, hydrophobic moiety; R, arginine; Y, tyrosine; X, any residue). Consequently, we were able to improve inhibitory potency or to convert inhibitors into strong activators: the former with an aromatic penultimate Hb residue and the latter with the HbYX motif. The PR peptide activator stimulated 20S proteasome in vitro to efficiently degrade protein substrates, such as α-synuclein and enolase, but also activated proteasome in cultured fibroblasts. The positive and negative PR modulators differently influenced the proteasome conformational dynamics and affected opening of the substrate entry pore. The resolved crystal structure showed PR inhibitor bound far from the active sites, at the proteasome outer face, in the pocket used by natural activators. Our studies indicate the opportunity to tune proteasome activity by allosteric regulators based on PR peptide scaffold.

Original languageEnglish (US)
JournalJournal of Medicinal Chemistry
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Proteasome Endopeptidase Complex
Proline
Human Activities
Arginine
Peptides
Synucleins
Phosphopyruvate Hydratase
Tyrosine
Catalytic Domain
Fibroblasts
Proteins

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Proline- and Arginine-Rich Peptides as Flexible Allosteric Modulators of Human Proteasome Activity. / Giziynska, Ma Agorzata; Witkowska, Julia; Karpowicz, Przemysaw; Rostankowski, Rafa; Chocron, Estrella S.; Pickering, Andrew M; Osmulski, Pawel; Gaczynska, Maria E; Jankowska, Elzbieta.

In: Journal of Medicinal Chemistry, 01.01.2018.

Research output: Contribution to journalArticle

Giziynska, Ma Agorzata ; Witkowska, Julia ; Karpowicz, Przemysaw ; Rostankowski, Rafa ; Chocron, Estrella S. ; Pickering, Andrew M ; Osmulski, Pawel ; Gaczynska, Maria E ; Jankowska, Elzbieta. / Proline- and Arginine-Rich Peptides as Flexible Allosteric Modulators of Human Proteasome Activity. In: Journal of Medicinal Chemistry. 2018.
@article{a12918bea6814d069d745721ed14e3ab,
title = "Proline- and Arginine-Rich Peptides as Flexible Allosteric Modulators of Human Proteasome Activity",
abstract = "Proline- and arginine-rich peptide PR11 is an allosteric inhibitor of 20S proteasome. We modified its sequence inter alia by introducing HbYX, RYX, or RHbX C-terminal extensions (Hb, hydrophobic moiety; R, arginine; Y, tyrosine; X, any residue). Consequently, we were able to improve inhibitory potency or to convert inhibitors into strong activators: the former with an aromatic penultimate Hb residue and the latter with the HbYX motif. The PR peptide activator stimulated 20S proteasome in vitro to efficiently degrade protein substrates, such as α-synuclein and enolase, but also activated proteasome in cultured fibroblasts. The positive and negative PR modulators differently influenced the proteasome conformational dynamics and affected opening of the substrate entry pore. The resolved crystal structure showed PR inhibitor bound far from the active sites, at the proteasome outer face, in the pocket used by natural activators. Our studies indicate the opportunity to tune proteasome activity by allosteric regulators based on PR peptide scaffold.",
author = "Giziynska, {Ma Agorzata} and Julia Witkowska and Przemysaw Karpowicz and Rafa Rostankowski and Chocron, {Estrella S.} and Pickering, {Andrew M} and Pawel Osmulski and Gaczynska, {Maria E} and Elzbieta Jankowska",
year = "2018",
month = "1",
day = "1",
doi = "10.1021/acs.jmedchem.8b01025",
language = "English (US)",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",

}

TY - JOUR

T1 - Proline- and Arginine-Rich Peptides as Flexible Allosteric Modulators of Human Proteasome Activity

AU - Giziynska, Ma Agorzata

AU - Witkowska, Julia

AU - Karpowicz, Przemysaw

AU - Rostankowski, Rafa

AU - Chocron, Estrella S.

AU - Pickering, Andrew M

AU - Osmulski, Pawel

AU - Gaczynska, Maria E

AU - Jankowska, Elzbieta

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Proline- and arginine-rich peptide PR11 is an allosteric inhibitor of 20S proteasome. We modified its sequence inter alia by introducing HbYX, RYX, or RHbX C-terminal extensions (Hb, hydrophobic moiety; R, arginine; Y, tyrosine; X, any residue). Consequently, we were able to improve inhibitory potency or to convert inhibitors into strong activators: the former with an aromatic penultimate Hb residue and the latter with the HbYX motif. The PR peptide activator stimulated 20S proteasome in vitro to efficiently degrade protein substrates, such as α-synuclein and enolase, but also activated proteasome in cultured fibroblasts. The positive and negative PR modulators differently influenced the proteasome conformational dynamics and affected opening of the substrate entry pore. The resolved crystal structure showed PR inhibitor bound far from the active sites, at the proteasome outer face, in the pocket used by natural activators. Our studies indicate the opportunity to tune proteasome activity by allosteric regulators based on PR peptide scaffold.

AB - Proline- and arginine-rich peptide PR11 is an allosteric inhibitor of 20S proteasome. We modified its sequence inter alia by introducing HbYX, RYX, or RHbX C-terminal extensions (Hb, hydrophobic moiety; R, arginine; Y, tyrosine; X, any residue). Consequently, we were able to improve inhibitory potency or to convert inhibitors into strong activators: the former with an aromatic penultimate Hb residue and the latter with the HbYX motif. The PR peptide activator stimulated 20S proteasome in vitro to efficiently degrade protein substrates, such as α-synuclein and enolase, but also activated proteasome in cultured fibroblasts. The positive and negative PR modulators differently influenced the proteasome conformational dynamics and affected opening of the substrate entry pore. The resolved crystal structure showed PR inhibitor bound far from the active sites, at the proteasome outer face, in the pocket used by natural activators. Our studies indicate the opportunity to tune proteasome activity by allosteric regulators based on PR peptide scaffold.

UR - http://www.scopus.com/inward/record.url?scp=85058220234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058220234&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.8b01025

DO - 10.1021/acs.jmedchem.8b01025

M3 - Article

C2 - 30452262

AN - SCOPUS:85058220234

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

ER -